LONA earnings: real EPS beat/miss history, analyst consensus Buy, P/E -0.25. Updated 2026-07-23.
LeonaBio (LONA) Research Hub
LeonaBio (LONA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 7.16 USD (+1.70%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.25, market cap 0.03B. This hub links to the full technical, earnings and options research available for LONA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 7.16 USD (+1.70%) |
| 52-week range | 6.72 USD – 10.1 USD |
| Trend regime | Range |
| 14-day RSI | 42.7 (Bearish) |
| Trailing P/E | -0.25 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
Available research for LONA
Covered Call on LONA: how it works, illustrative setup around the real 7.16 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LONA: how it works, illustrative setup around the real 7.16 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LONA: how it works, illustrative setup around the real 7.16 USD price, max profit/loss, breakeven and when to use it. Educational.
LONA technical analysis: range, last 7.16 USD, RSI 42.7, 52w range 6.72 USD–10.1 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is LONA in?
LeonaBio (LONA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is LONA in an uptrend or downtrend?
As of 2026-09-11, LONA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LONA's trailing P/E ratio?
LONA's trailing P/E is -0.25, with a market cap of 0.03B. See the earnings research page for full valuation detail.